Thursday, February 09, 2017 11:25:19 AM
If any type of Titan/Verb/JnJ/Google partnership was announced this stock will go to multiple dollars quickly. Verb wouldn't even need to fund the $75m needed to get to commercialization. Titan would get most of the money through the warrants. Verb would only need to make a minimal initial investment which would be ideal as that would limit dilution. Perhaps a multi tiered agreement similar to the Medtronic/Mazor deal. The risk that keeps this stock at the PPS it's at now is virtually eliminated. It's conceivable that an uplist could happen as well. It would have a cascade effect. Verb/JnJ/Google have as close to unlimited funds as you can get and for little more than a press release and some pocket change they could partner with a company that is relatively close to completing a novel robotic surgery solution that could be one of their competitors in a few years! I think that the autonomous features of the Verb platform will keep their platform from being commercialized for many years. As McNally stated in his Noble presentation they will need to clear a more rigorous regulatory process. Also seems almost certain they don't have a single port option.
Maybe I'm seeing this through rose colored glasses but I see huge upside for both companies in a partnership.
Thanks to all who contributed this VERY intriguing DD.
Recent TMD News
- L'Organisme canadien de réglementation des investissements permet la reprise de la négociation - TMD • PR Newswire (Canada) • 06/05/2023 05:46:00 PM
- IIROC Trade Resumption - TMD • PR Newswire (Canada) • 06/05/2023 05:37:00 PM
- Suspension de la négociation par l'Organisme canadien de réglementation des investissements - TMD • PR Newswire (Canada) • 06/05/2023 05:33:00 PM
- Canadian Investment Regulatory Organization Trading Halt - TMD • PR Newswire (Canada) • 06/05/2023 05:30:00 PM
- L'OCRCVM permet la reprise de la négociation - TMD • PR Newswire (Canada) • 05/26/2023 06:45:00 PM
- IIROC Trade Resumption - TMD • PR Newswire (Canada) • 05/26/2023 06:42:00 PM
- IIROC Trading Halt - TMD • PR Newswire (Canada) • 05/26/2023 06:16:00 PM
FEATURED NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM